{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T00:10:28Z","timestamp":1759191028370,"version":"3.44.0"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T00:00:00Z","timestamp":1759104000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T00:00:00Z","timestamp":1759104000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Med Imaging"],"DOI":"10.1186\/s12880-025-01938-0","type":"journal-article","created":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T13:17:04Z","timestamp":1759151824000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Gd-EOB-DTPA-enhanced hepatobiliary phase MRI characteristics of inflammatory hepatic adenoma"],"prefix":"10.1186","volume":"25","author":[{"given":"Yiheng","family":"Zheng","sequence":"first","affiliation":[]},{"given":"Ermin","family":"Cai","sequence":"additional","affiliation":[]},{"given":"Mengsu","family":"Zeng","sequence":"additional","affiliation":[]},{"given":"Mingliang","family":"Wang","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2025,9,29]]},"reference":[{"issue":"3","key":"1938_CR1","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1002\/hep.21743","volume":"46","author":"P Bioulac-Sage","year":"2007","unstructured":"Bioulac-Sage P, Rebouissou S, Thomas C, et al. Hepatocellular adenoma subtype classification using molecular markers and immunohistochemistry. Hepatology (Baltimore MD). 2007;46(3):740\u20138. https:\/\/doi.org\/10.1002\/hep.21743.","journal-title":"Hepatology (Baltimore MD)"},{"issue":"2","key":"1938_CR2","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1053\/j.semdp.2016.12.007","volume":"34","author":"P Bioulac-Sage","year":"2017","unstructured":"Bioulac-Sage P, Sempoux C, Balabaud C. Hepatocellular adenoma: classification, variants and clinical relevance. Semin Diagn Pathol. 2017;34(2):112\u201325. https:\/\/doi.org\/10.1053\/j.semdp.2016.12.007.","journal-title":"Semin Diagn Pathol"},{"issue":"20","key":"1938_CR3","doi-asserted-by":"publisher","first-page":"2442","DOI":"10.3748\/wjg.v25.i20.2442","volume":"25","author":"M Renzulli","year":"2019","unstructured":"Renzulli M, Clemente A, Tovoli F, et al. Hepatocellular adenoma: an unsolved diagnostic enigma. World J Gastroenterol. 2019;25(20):2442\u20139. https:\/\/doi.org\/10.3748\/wjg.v25.i20.2442.","journal-title":"World J Gastroenterol"},{"key":"1938_CR4","unstructured":"Wang P, Shao H, Ban X, et al. The classification and clinicopathological analysis of hepatocellular adenoma based on immunohisto-chemistry[J]. Chin J Hepatobiliary Surg. 2019;25(7):4."},{"issue":"2","key":"1938_CR5","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1016\/j.jhep.2016.04.001","volume":"65","author":"European Association for the Study of the Liver (EASL)","year":"2016","unstructured":"European Association for the Study of the Liver (EASL). EASL clinical practice guidelines on the management of benign liver tumours. J Hepatol. 2016;65(2):386\u201398. https:\/\/doi.org\/10.1016\/j.jhep.2016.04.001.","journal-title":"J Hepatol"},{"issue":"9","key":"1938_CR6","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1056\/NEJM197602262940904","volume":"294","author":"HA Edmondson","year":"1976","unstructured":"Edmondson HA, Henderson B, Benton B. Liver-cell adenomas associated with use of oral contraceptives. N Engl J Med. 1976;294(9):470\u20132. https:\/\/doi.org\/10.1056\/NEJM197602262940904.","journal-title":"N Engl J Med"},{"key":"1938_CR7","unstructured":"Liu G, Yang S, Gong L, et al. MRI features identify subtype classification of hepatocellular adenoma[J]. Clin Radiol. 2021;40(3):6."},{"key":"1938_CR8","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.ejrad.2018.01.023","volume":"100","author":"H Wang","year":"2018","unstructured":"Wang H, Yang C, Rao S, et al. MR imaging of hepatocellular adenomas on genotype-phenotype classification: A report from China. Eur J Radiol. 2018;100:135\u201341. https:\/\/doi.org\/10.1016\/j.ejrad.2018.01.023.","journal-title":"Eur J Radiol"},{"issue":"4","key":"1938_CR9","doi-asserted-by":"publisher","first-page":"680","DOI":"10.1111\/jgh.14903","volume":"35","author":"WC Huang","year":"2020","unstructured":"Huang WC, Liau JY, Jeng YM, et al. Hepatocellular adenoma in taiwan: distinct ensemble of male predominance, overweight\/obesity, and inflammatory subtype. J Gastroenterol Hepatol. 2020;35(4):680\u20138. https:\/\/doi.org\/10.1111\/jgh.14903.","journal-title":"J Gastroenterol Hepatol"},{"issue":"6","key":"1938_CR10","doi-asserted-by":"publisher","first-page":"3497","DOI":"10.1007\/s00330-020-06726-8","volume":"30","author":"TA Auer","year":"2020","unstructured":"Auer TA, Fehrenbach U, Grieser C, et al. Hepatocellular adenomas: is there additional value in using Gd-EOB-enhanced MRI for subtype differentiation? Eur Radiol. 2020;30(6):3497\u2013506. https:\/\/doi.org\/10.1007\/s00330-020-06726-8.","journal-title":"Eur Radiol"},{"issue":"5","key":"1938_CR11","doi-asserted-by":"publisher","first-page":"2436","DOI":"10.1007\/s00330-018-5784-5","volume":"29","author":"S Bise","year":"2019","unstructured":"Bise S, Frulio N, Hocquelet A, et al. New MRI features improve subtype classification of hepatocellular adenoma. Eur Radiol. 2019;29(5):2436\u201347. https:\/\/doi.org\/10.1007\/s00330-018-5784-5.","journal-title":"Eur Radiol"},{"issue":"1","key":"1938_CR12","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1148\/radiol.2015142449","volume":"279","author":"JR Tse","year":"2016","unstructured":"Tse JR, Naini BV, Lu DS. Qualitative and quantitative Gadoxetic Acid-enhanced MR imaging helps subtype hepatocellular adenomas. Radiology. 2016;279(1):118\u201327. https:\/\/doi.org\/10.1148\/radiol.2015142449.","journal-title":"Radiology"},{"issue":"3","key":"1938_CR13","doi-asserted-by":"publisher","first-page":"808","DOI":"10.1002\/hep.22417","volume":"48","author":"H Laumonier","year":"2008","unstructured":"Laumonier H, Bioulac-Sage P, Laurent C, et al. Hepatocellular adenomas: magnetic resonance imaging features as a function of molecular pathological classification. Hepatology (Baltimore MD). 2008;48(3):808\u201318. https:\/\/doi.org\/10.1002\/hep.22417.","journal-title":"Hepatology (Baltimore MD)"},{"issue":"5","key":"1938_CR14","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1016\/j.rcl.2022.05.005","volume":"60","author":"E Reizine","year":"2022","unstructured":"Reizine E, Mul\u00e9 S, Luciani A. Focal benign liver lesions and their diagnostic pitfalls. Radiol Clin North Am. 2022;60(5):755\u201373. https:\/\/doi.org\/10.1016\/j.rcl.2022.05.005.","journal-title":"Radiol Clin North Am"},{"issue":"1","key":"1938_CR15","doi-asserted-by":"publisher","first-page":"28","DOI":"10.2214\/AJR.22.27989","volume":"220","author":"TH Kim","year":"2023","unstructured":"Kim TH, Woo S, Ebrahimzadeh S, McInnes MDF, Gerst SR, Do RK. Hepatic adenoma subtypes on hepatobiliary phase of Gadoxetic Acid-Enhanced MRI: systematic review and Meta-Analysis. AJR Am J Roentgenol. 2023;220(1):28\u201338. https:\/\/doi.org\/10.2214\/AJR.22.27989.","journal-title":"AJR Am J Roentgenol"},{"issue":"1","key":"1938_CR16","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1148\/rg.2020190037","volume":"40","author":"N Fujita","year":"2020","unstructured":"Fujita N, Nishie A, Asayama Y, et al. Hyperintense liver masses at hepatobiliary phase Gadoxetic Acid-enhanced MRI: imaging appearances and clinical importance. Radiographics: Rev Publication Radiological Soc North Am Inc. 2020;40(1):72\u201394. https:\/\/doi.org\/10.1148\/rg.2020190037.","journal-title":"Radiographics: Rev Publication Radiological Soc North Am Inc"},{"issue":"01","key":"1938_CR17","doi-asserted-by":"publisher","first-page":"114","DOI":"10.3760\/cma.j.cn112149-20231121-00411","volume":"58","author":"D Li Ruokun","year":"2024","unstructured":"Li Ruokun D, Lin Y, Fuhua. MRI findings of benign hepatic tumors[J]. Chinese J Radiol. 2024;58(01):114\u20138. https:\/\/doi.org\/10.3760\/cma.j.cn112149-20231121-00411.","journal-title":"[J]Chinese J Radiol 2024"},{"issue":"1","key":"1938_CR18","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1148\/radiol.2361040338","volume":"236","author":"L Grazioli","year":"2005","unstructured":"Grazioli L, Morana G, Kirchin MA, et al. Accurate differentiation of focal nodular hyperplasia from hepatic adenoma at gadobenate dimeglumine-enhanced MR imaging: prospective study. Radiology. 2005;236(1):166\u201377. https:\/\/doi.org\/10.1148\/radiol.2361040338.","journal-title":"Radiology"},{"issue":"7","key":"1938_CR19","doi-asserted-by":"publisher","first-page":"3791","DOI":"10.1007\/s00330-019-06150-7","volume":"29","author":"E Reizine","year":"2019","unstructured":"Reizine E, Ronot M, Pigneur F, et al. Iso- or hyperintensity of hepatocellular adenomas on hepatobiliary phase does not always correspond to hepatospecific contrast-agent uptake: importance for tumor subtyping. Eur Radiol. 2019;29(7):3791\u2013801. https:\/\/doi.org\/10.1007\/s00330-019-06150-7.","journal-title":"Eur Radiol"}],"container-title":["BMC Medical Imaging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12880-025-01938-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12880-025-01938-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12880-025-01938-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T13:17:08Z","timestamp":1759151828000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcmedimaging.biomedcentral.com\/articles\/10.1186\/s12880-025-01938-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,29]]},"references-count":19,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1938"],"URL":"https:\/\/doi.org\/10.1186\/s12880-025-01938-0","relation":{},"ISSN":["1471-2342"],"issn-type":[{"value":"1471-2342","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,29]]},"assertion":[{"value":"15 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 September 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was performed in line with the principles of the Declaration of Helsinki. The requirement for informed consent was waived by the Ethics Committee of Zhongshan Hospital of Fudan University because of the retrospective nature of the study. Patients were not required to give informed consent to the study because the analysis used anonymous clinical data that were obtained after each patient agreed to treatment by written consent. The study is approved by Zhongshan Hospital of Fudan University institutional review board (Approval number: B2021-366). All experiments were performed in accordance with relevant guidelines and regulations.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"388"}}